Upstream Bio (UPB) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $53.9 million.

  • Upstream Bio's Shares Outstanding (Weighted Average) rose 168392.92% to $53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.9 million, marking a year-over-year increase of 168392.92%. This contributed to the annual value of $13.7 million for FY2024, which is 36321.79% up from last year.
  • Per Upstream Bio's latest filing, its Shares Outstanding (Weighted Average) stood at $53.9 million for Q3 2025, which was up 168392.92% from $53.8 million recorded in Q2 2025.
  • Upstream Bio's 5-year Shares Outstanding (Weighted Average) high stood at $53.9 million for Q3 2025, and its period low was $3.0 million during Q4 2023.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $21.1 million, with a median of $3.0 million in 2024.
  • As far as peak fluctuations go, Upstream Bio's Shares Outstanding (Weighted Average) surged by 217.76% in 2024, and later skyrocketed by 168987.84% in 2025.
  • Upstream Bio's Shares Outstanding (Weighted Average) (Quarter) stood at $3.0 million in 2023, then surged by 363.22% to $13.7 million in 2024, then soared by 294.17% to $53.9 million in 2025.
  • Its last three reported values are $53.9 million in Q3 2025, $53.8 million for Q2 2025, and $53.6 million during Q1 2025.